𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Review of recent placebo-controlled trials utilizing phytotherapeutic agents for treatment of BPH

✍ Scribed by Lowe, Franklin C.; Dreikorn, Kurt; Borkowski, A.; Braeckman, J.; Denis, L.; Ferrari, P.; Gerber, G.; Levin, R.; Perrin, P.; Senge, T.

Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
195 KB
Volume
37
Category
Article
ISSN
0270-4137

No coin nor oath required. For personal study only.

✦ Synopsis

BACKGROUND.

In order to assess the efficacy of phytotherapeutic agents for the treatment of benign prostatic hyperplasia (BPH), a review of recently published double-blind placebocontrolled trials was undertaken. METHODS. Only those studies reviewed by the Other Medical Therapies Committee of the Fourth International Consultation on BPH were included. RESULTS. These studies suggest a possible benefit for the use of phytotherapeutic preparations in the treatment of BPH. CONCLUSIONS. These studies need to be confirmed in larger long-term placebo-controlled studies in order to ascertain the true efficacy of these agents.

πŸ“œ SIMILAR VOLUMES

Double-blind, placebo-controlled trial t
Double-blind, placebo-controlled trial to assess the efficacy and tolerability of mepartricin in the treatment of BPH
✍ Denis, Louis; Pagano, Francesco; Nonis, Atanasio; Robertson, Chris; Romano, Paol πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 76 KB πŸ‘ 2 views

BACKGROUND. Mepartricin, a semisynthetic polyene derivative with a favorable effect on urethro-prostatic function, was clinically evaluated, adopting the diagnostic and research criteria recommended by the First International Consultation on BPH. METHODS. A multicenter, randomized, double-blind, par

Atropine for the treatment of biliary tr
Atropine for the treatment of biliary tract pain: a double-blind, placebo-controlled trial
✍ Steven G Rothrock; Steven M Green; Eileen Gorton πŸ“‚ Article πŸ“… 1993 πŸ› Elsevier Science 🌐 English βš– 359 KB

Interventions: Subjects were randomized to receive either 0.6 mg (0.5 mL)IM atropine or normal saline placebo in a doubleblinded manner. If pain relief with the initial injection was inadequate, patients received the alternate injection. Pain was assessed by visual analog scale (0 to 100 mm) before